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Abstract
The anaphase-promoting complex (APC) is an E3 ubiquitin ligase which controls ubiquitination and degradation of multiple
cell cycle regulatory proteins. During infection, human cytomegalovirus (HCMV), a widespread pathogen, not only
phosphorylates the APC coactivator Cdh1 via the multifunctional viral kinase pUL97, it also promotes degradation of APC
subunits via an unknown mechanism. Using a proteomics approach, we found that a recently identified HCMV protein,
pUL21a, interacted with the APC. Importantly, we determined that expression of pUL21a was necessary and sufficient for
proteasome-dependent degradation of APC subunits APC4 and APC5. This resulted in APC disruption and required pUL21a
binding to the APC. We have identified the proline-arginine amino acid pair at residues 109–110 in pUL21a to be critical for
its ability to bind and regulate the APC. A point mutant virus in which proline-arginine were mutated to alanines (PR-AA)
grew at wild-type levels. However, a double mutant virus in which the viral ability to regulate the APC was abrogated by
both PR-AA point mutation and UL97 deletion was markedly more attenuated compared to the UL97 deletion virus alone.
This suggests that these mutations are synthetically lethal, and that HCMV exploits two viral factors to ensure successful
disruption of the APC to overcome its restriction on virus infection. This study reveals the HCMV protein pUL21a as a novel
APC regulator and uncovers a unique viral mechanism to subvert APC activity.
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Introduction
Regulation of protein degradation plays a key role in many
cellular processes ranging from cell cycle progression, innate
immunity, and antigen presentation to the turnover of misfolded
or oxidized proteins. Most degradation is carried out by the
ubiquitin-proteasome system (UPS). Ubiquitin is added to proteins
by a cascade of ubiquitin conjugating enzymes, resulting in a
polyubiquitinated protein which is subsequently degraded by the
26S proteasome. As a means to regulate protein function, it is no
surprise that many viruses have co-opted the UPS for their own
benefit. Viruses can promote proteasome degradation of antiviral
host proteins either by encoding their own E3 ubiquitin ligase,
targeting proteins to a cellular E3 ligase, or even inducing
ubiquitin-independent degradation of targets. Examples of viral
E3 ligases include the herpes simplex virus-1 protein ICP0 [1] and
Kaposi’s sarcoma-associated herpesvirus proteins K3 and K5 (for
a review, see [2]). Viral proteins that can hijack a cellular E3 ligase
include human immunodeficiency virus-1 vpr and vif (for a review,
see [3]), paramyxovirus V [4], and human papillomavirus E6 and
E7 (for a review, see [5]). Finally, the human cytomegalovirus
(HCMV) protein pp71 uses a ubiquitin-independent mechanism
to target the Rb and hDaxx proteins [6,7]. In fact, pharmacolog-
ical inhibition of the proteasome blocks multiple stages of the viral
life cycle, suggesting that viruses rely on activities of the UPS for
their replication [8–12]. On the other hand, viruses must also
modulate cellular E3 ligase activity in order to replicate because
ubiquitination regulates many important cellular processes central
to virus infection. The SV40 large T antigen inhibits the SCFfbw7
ubiquitin ligase to increase cyclin E levels [13], and influenza virus
NS1 inhibits TRIM 25-mediated ubiquitination of RIG-I, thereby
attenuating interferon production [14].
The anaphase-promoting complex (APC) or cyclosome is a
macromolecular complex that contains cullin-ring E3 ubiquitin
ligase activity and is conserved across all eukaryotes (for a review,
see [15]). It has at least eleven subunits and two co-activator
proteins (CDC20 (cell-division cycle protein 20) and Cdh1
(CDC20 homologue 1)), which are separated into three sub-
complexes. These include the cullin-ring ligase domain (composed
of APC2, 10, and 11), the specificity arm (composed of APC3, 6, 7,
and 8), and the bridge (composed of APC1, 4, and 5). Cdh1 and
CDC20 activate APC activity to prevent premature entry into S
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phase and to promote progression through mitosis, respectively.
The APC complex ubiquitinates more than 40 proteins, including
A- and B- type cyclins, to regulate their stability. It also regulates
degradation of its own coactivator proteins, Cdh1 and CDC20, as
a form of feedback regulation. Due to its central role in cell cycle
progression, the APC is also a promising target for anti-cancer
therapeutics [16].
Many viruses modulate the host cell cycle to establish optimal
conditions for their replication. Several viral proteins have been
reported to target the APC, possibly to force the cell into an S phase-
like biochemical environment to promote efficient viral replication.
Proteins from adenovirus, chicken anemia virus, human papillo-
mavirus, human T-lymphotropic virus, hepatitis B virus, para-
poxvirus, and HCMV have been reported to regulate the function
of the APC [17–24]. However, the mechanisms used by these
viruses during infection to subvert the APC are largely unknown.
HCMV is a globally important opportunistic pathogen that
causes severe diseases in immunocompromised individuals and is
the leading viral cause of congenital diseases. This virus stimulates
cell cycle progression of quiescent cells into an S phase-like
environment but concurrently blocks host DNA synthesis [25].
HCMV promotes cell cycle progression likely in part by
inactivating Rb [6,26] and regulating the APC [24,27,28]. It has
been reported that HCMV has two means to regulate the APC.
The multifunctional viral kinase pUL97 phosphorylates the APC
coactivator Cdh1, thus likely inhibiting its activity [24]. Nonethe-
less, abrogation of UL97 alone only results in a modest increase in
APC activity during infection [24]. Independent of UL97-
mediated Cdh1 regulation, HCMV also induces degradation of
two APC subunits, APC4 and APC5, leading to the dissociation of
the complex during infection [24]. The viral factor and associated
mechanism responsible for regulating degradation of the APC
subunits have not been identified.
In this study, we demonstrate that the HCMV protein pUL21a
interacts with the APC, resulting in proteasome-dependent
degradation of APC4 and APC5. Expression of pUL21a
dissociates the APC cullin-ring ligase subcomplex from its
specificity arm. This regulation alters APC activity and increases
levels of a subset of APC-regulated cell cycle proteins. We have
identified residues proline-arginine (PR109-110) in pUL21a to be
critical for its ability to bind and regulate the APC. A mutant virus
in which the viral ability to regulate the APC is abrogated by both
alanine substitution of proline-arginine residues in pUL21a and
UL97 deletion is markedly more defective compared to the pUL97
deletion virus alone. This suggests that HCMV has evolved an
invasive strategy of using both viral factors to regulate the APC to
facilitate its infection. Our study has identified the HCMV protein
pUL21a as a novel APC regulator and elucidated a unique
mechanism to subvert APC activity.
Results
pUL21a Interacts with the Anaphase-Promoting Complex
(APC)
HCMV pUL21a is a 15 kDa, highly unstable protein that is
expressed with early kinetics [29]. One identified function of this
protein is to facilitate efficient viral DNA synthesis [30]. However,
this protein shares no significant homology with any known
protein. To provide mechanistic insight into its activity, we used a
proteomics approach to identify interacting partners of pUL21a
during infection. We created a recombinant virus (ADgfpUL21a)
in which the UL21a coding sequence was tagged with the green
fluorescent protein (GFP) coding sequence. This virus grew with
wild-type kinetics, and the tagged protein was fortuitously much
more stable than native pUL21a [29]. A GFP tag can stabilize
certain fusion proteins [31], and made it possible to detect
interacting proteins in our study. We infected fibroblasts with
either ADgfpUL21a or control HCMV (ADgfp) that expressed free
GFP only. At 48 hours post infection (hpi), we isolated the protein
complexes from infected cells by a rapid one-step immunoaffinity
purification on magnetic beads coated with GFP antibody-coupled
protein A. Electrophoresis analysis revealed multiple protein bands
that were specific to the pUL21a-containing sample (Figure 1A).
We analyzed pUL21a-specific protein bands by mass spectrometry
and identified the proteins depicted with arrows as APC specificity
arm subunits, APC3, APC7, and APC8 (Table S1).
We validated these interactions in HCMV infected cells by co-
immunoprecipitation followed by immunoblot analysis. Here we
used APC3 and APC8 as the marker for the APC complex. Pull-
down of pGFP-UL21a, but not the GFP control, isolated both
APC3 and APC8 (Figure 1B). The lower band detected by APC8
antibody was nonspecific as it neither co-immunoprecipitated with
APC3 antibody (Figure 1B) nor was affected by shRNA
knockdown of APC8 (Figure S1). In the reciprocal experiment,
APC3 antibody co-immunoprecipitated APC8 and pGFP-UL21a
but not GFP. Neither GFP nor APC3 antibody co-immunopre-
cipitated cellular PCNA (Figure 1B), and an antibody against HA
did not co-immunoprecipitate any of the proteins detected here
(data not shown), thus providing additional evidence for the
specificity of these interactions. As pGFP-UL21a is co-immuno-
precipitated with multiple APC subunits, we interpret the result to
suggest that pUL21a binds to the APC complex, even though the
precise subunit where pUL21a directly interacts with remains
unknown.
To determine if this interaction also occurred with native
pUL21a, we performed co-immunoprecipitation assays on lysates
from cells infected with wild-type virus (ADgfp), and we also
included lysate from cells infected with UL21a deletion virus
(ADsubUL21a) as a negative control (Figure 1C). Infected cells
were treated with proteasome inhibitor, MG132, as pUL21a was
highly unstable and otherwise could not accumulate to levels
allowing reproducible detection of this interaction [29]. In the
Author Summary
In this study, we report an intriguing mechanism used by
human cytomegalovirus (HCMV) to regulate a cellular E3
ubiquitin ligase, the anaphase promoting complex (APC).
The ability to hijack the ubiquitin-proteasome system for
regulating protein degradation and to manipulate the cell
cycle for viral genome synthesis is critical in many viral
infections. The APC is a master cell cycle modulator that
targets a number of regulatory proteins for proteasomal
degradation. It can prevent cells from entry into S-phase,
thus creating a hindrance for viruses needing to coerce
cells into a cellular environment favorable for viral DNA
synthesis. We have identified an HCMV protein, pUL21a,
which uses a seemingly counterintuitive mechanism to
regulate the APC. It interacts with the APC to target the
subunits of this ubiquitin ligase for proteasomal degrada-
tion. This causes disruption of the complex and reduces its
activity. Furthermore, a virus lacking pUL21a and pUL97,
which is another HCMV-encoded APC regulator, was highly
attenuated when compared to loss of UL97 alone,
suggesting that HCMV uses two proteins to fully disarm
the APC. This study identifies a herpesviral protein that
uses a unique, proteasome-dependent mechanism to
regulate the activity of this prominent cellular E3 ubiquitin
ligase.
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presence of MG132, the level of native pUL21a was markedly
increased and could be co-immunoprecipitated with APC3
antibody. This interaction was specific as the antibody did not
co-immunoprecipitate PCNA or the viral DNA polymerase
accessory factor UL44.
To test if pUL21a was able to bind to the APC in the absence of
other HCMV proteins, we performed co-immunoprecipitation
assay on lysates from 293T cells transfected with constructs
expressing the GFP-amino terminal tagged UL21a (gfpUL21awt)
or UL21a carrying two stop codons at its amino terminus to
abrogate pUL21a expression (gfpUL21astop) (Figure 1D). Both
gfpUL21awt and gfpUL21astop were expressed at equal levels but only
gfpUL21awt associated with APC3 or APC8. Additionally, APC3
antibody co-immunoprecipitated gfpUL21awt but not gfpUL21astop.
We conclude that pUL21a interacts with the APC and does not
require other HCMV proteins for this interaction to occur.
Figure 1. pUL21a interacts with the APC. (A) Identification of pUL21a interacting partners. MRC-5 cells were infected with ADgfp or ADgfpUL21a
at an MOI of 5, collected at 48 hpi, and were immunoprecipitated with GFP antibody. Eluted proteins were run on an SDS-containing polyacrylamide
gel and silver stained. The bands indicated with an arrow were identified by mass spectrometry as APC3 (100 kDa), APC7, and APC8 (both at 65 kDa).
(B) GFP-tagged pUL21a interacts with the APC in HCMV infection. MRC-5 cells were infected as described in panel A, and lysates were subjected to co-
immunoprecipitation with GFP or APC3 mouse monoclonal antibodies. Cell lysates and eluted proteins were analyzed by immunoblotting with
indicated antibodies. GFP blots were cropped to save space but were from the same lane and exposed film. Non-specific cross-reacting bands are
indicated by asterisk (see text). Partial proteolysis was often seen with the GFP-tagged UL21a protein, particularly in cell lysate samples. (C) Native
pUL21a interacts with the APC in HCMV infection. MRC-5 cells were infected with ADgfp or ADsubUL21a (as described in Materials and Methods) in
the presence (+) or absence (2) of 10 mM MG132. Cell lysates were prepared at 24 hpi and immunoprecipitated with APC3 antibody. Cell lysates and
eluted proteins were analyzed by immunoblotting. (D) Interaction of pUL21a with the APC does not require other viral proteins. 293T cells were
transfected with plasmids expressing gfpUL21awt or gfpUL21astop. Cells were collected 72 hours later and cell lysates were immunoprecipitated as in
panel B. Cell lysates and eluted proteins were analyzed by immunoblotting. PCNA and pUL44 were used as cellular and viral negative controls,
respectively.
doi:10.1371/journal.ppat.1002789.g001
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The Carboxyl-Terminus of pUL21a Contains the APC
Binding Site
To begin understanding the nature of this interaction, we
identified the APC-binding domain of pUL21a. Sequence
alignment of pUL21a with its homologues in chimpanzee CMV
(CCMV) and Rhesus CMV (RhCMV) revealed a highly conserved
N-terminus (residues 1–47), divergent middle region (residues 48–
83), and C-terminus that contained several conserved residues
(residues 84–123), including a proline-arginine (PR) pair at
residues 109–110 (Figure 2A). We created a series of truncation
mutations targeting each region in the GFP-tagged pUL21a, and
tested the ability of mutant UL21a proteins to interact with the
APC in 293T cells (Figure 2B). All mutants were expressed at
similar levels and were efficiently immunoprecipitated by the GFP
antibody (Figure 2C, and data not shown). As expected, full-length
gfpUL21awt co-immunoprecipitated both APC3 and APC8 while
the gfpUL21astop mutant did not. Importantly, while the carboxyl-
terminal fragment of pUL21a consistently co-immunoprecipitated
APC3 and APC8, the amino-terminal and middle fragments were
unable to do so. Thus the carboxyl-terminus of pUL21a contains
the APC binding domain.
To define the precise sequence of the APC binding site, we
made gfpUL21a mutants in which each of five conserved residue
clusters within its carboxyl terminus were individually substituted
with alanine residues (Figure 2A). As a control, we also made
alanine substitutions for the non-conserved proline-histidine pair
at residues 111–112 (PH111-112AA) (Figure 2A). All mutants were
stable and were efficiently pulled down by the GFP antibody
(Figure 2D, and data not shown). Among them, only the PR109-
110AA mutant lost the ability to bind to the APC. Substitutions of
the adjoining non-conserved residues (PH111-112AA) had no
effect on APC binding. To validate the result in the context of
infection, we constructed recombinant HCMV viruses expressing
GFP-tagged or native forms of PR109-110AA or PH111-112AA
pUL21a variants (ADgfpUL21aPR-AA, ADgfpUL21aPH-AA, AD-
pmUL21aPR-AA, and ADpmUL21aPH-AA). During infection, a
reciprocal interaction between gfpUL21aPH-AA and APC3 could
be detected while gfpUL21aPR-AA and APC3 did not interact
(Figure 2E). Furthermore, untagged pUL21aPH-AA, but not
pUL21aPR-AA, was co-immunoprecipitated with APC3 when
stabilized by MG132 (Figure S2). Together, these results
indicate that the carboxyl terminus of pUL21a contains the
APC binding domain and the residues PR109–110 are critical for
this binding.
Binding of pUL21a to the APC Promotes Degradation of
APC4 and APC5 Subunits
It has recently been reported that the APC bridge subunits
APC4 and APC5 are degraded during HCMV infection and the
complex dissociates [24]. To test if pUL21a was required for these
events, we first examined APC subunit accumulation during
infection with or without pUL21a. Levels of APC4 and APC5
proteins were markedly reduced during wild-type infection relative
to mock-infected cells at 24 hpi (Figure 3A). However, no
reduction was observed in APC4 and APC5 levels during infection
with the UL21a-deletion virus. The pUL21a-deficient virus fails to
express late viral genes due to a defect in viral DNA synthesis [30].
To rule out any role of late genes in APC4 and APC5 degradation,
we treated infected cells with phosphonoacetic acid (PAA) to block
viral DNA synthesis and late gene expression. APC4 and APC5
levels were reduced during infection with wild-type virus but
remained elevated during infection with the UL21a-deletion virus,
even following PAA treatment. Furthermore, there was no
appreciable difference in APC4 and APC5 transcript levels
between wild-type and deletion virus infections (Figure 3B). These
data suggest that the changes in APC4 and APC5 protein levels
occur at the level of protein stability. Consistent with this
hypothesis, MG132 enhanced APC4 and APC5 protein levels
during infection with wild-type but not deletion virus (Figure 3C).
Thus, pUL21a-mediated loss of APC4 and APC5 was due to
proteasomal degradation. Moreover, the APC binding mutant
virus ADpmUL21aPR-AA was unable to degrade APC4 and APC5
while the ADpmUL21aPH-AA virus was as efficient as the wild-type
control virus. These data support the conclusion that pUL21a
binding to the APC promotes proteasomal degradation of APC4
and APC5.
We next tested if the APC binding ability of pUL21a was also
required for APC dissociation during infection. In this experiment,
we used APC3 and APC10 as the marker for the specificity arm
and cullin-ring ligase subcomplex of the APC, respectively. These
two subcomplexes sit on opposite sides of the APC. APC10 has
been proposed to bind APC substrates along with coactivator
proteins, including Cdh1 [32]. APC10 associates with APC2 and
APC11 of the ligase subcomplex, but its location in the inner
cavity of the APC allows for contact with APC3 and APC6 of the
specificity arm. In cells infected with ADpmUL21aPR-AA, total
levels of APC3 and APC10 were similar to those in cells infected
with ADpmUL21aPH-AA, allowing for a direct analysis of the
efficiency of their association with the complex (Figure 3D). APC3
could not co-immunoprecipitate APC10 in ADpmUL21aPH-AA-
infected cells, consistent with dissociation of the complex in the
presence of functional pUL21a. In cells infected with ADpmU-
L21aPR-AA, APC3 was able to pull down APC10 efficiently,
indicating that the two subcomplexes remained associated. Finally,
the integrity of the APC during ADpmUL21aPH-AA infection was
largely restored upon addition of MG132, even though total
protein levels were reduced likely due to MG132-induced cell
death (Figure 3D, and data not shown). These data were
recapitulated during infection of wild-type and UL21a deletion
viruses (Figure S3). Our data provides strong evidence supporting
the model that binding of pUL21a to the APC induces
degradation of the APC bridge arm resulting in complex
dissociation.
As APC8 was co-immunoprecipitated with pUL21a in our
original screen, it raised the possibility that pUL21a might require
APC8 to target APC4 and APC5. For instance, pUL21a might
bind to APC8 to disrupt the structure of the APC leading to APC4
and APC5 degradation, or it might use APC8 as a docking site for
recruiting protein degradation enzymes to target APC4 and
APC5. To test this, we depleted APC8 in these cells by shRNA
knockdown (Figure S4). Following shRNA depletion of APC8, the
APC4 and APC5 levels remained reduced in cells infected with
wild-type virus compared to those with UL21a-deletion virus, even
though APC knockdown did seem to affect the overall stability of
APC4 and APC5 in pUL21a-independent manner (Figure S4).
This suggests that pUL21a-mediated degradation of APC4 and
APC5 is independent of APC8.
pUL21a Expression Regulates APC Activity during HCMV
Infection
To determine the functional consequence of pUL21a-depen-
dent APC dissociation, we first analyzed the accumulation of APC
substrates during wild-type or UL21a-deletion virus infection. The
protein levels of APC substrates Cdh1 (that is also an APC co-
activator) and geminin were markedly increased in wild-type virus
infection as previously reported [27,33] (Figure 4A). However,
their levels were reduced during infection with the UL21a-deletion
Proteasomal Disruption of an E3 Ligase by pUL21a
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virus, suggesting increased APC activity. The geminin transcript
accumulated to wild-type levels even without pUL21a, providing
evidence that the difference in protein accumulation was not due
to transcriptional regulation (Figure 4B). PAA treatment had no
effect on substrate accumulation, ruling out pUL21a-mediated late
gene expression as the source of the observed phenotype (Figure
S5A). MG132 largely restored substrate levels during UL21a
deletion viral infection, indicating that the difference is likely due
Figure 2. The carboxyl-terminus of pUL21a contains the APC binding site. (A) Amino acid alignment of UL21a proteins from human,
chimpanzee, and rhesus CMVs. Boxes above aligned proteins divide the protein into N-terminal, Middle, and C-terminal regions. Conserved residues
at the C-terminal region targeted for alanine substitution are boxed. (B) Diagram of UL21a truncation mutants analyzed in this study. (C) The C-
terminus of pUL21a binds to the APC. GFP-tagged UL21a truncation mutant proteins were expressed in 293T cells by transfection, cells were
collected at 72 hours, and lysates were immunoprecipitated with GFP antibody. Cell lysates and eluted proteins were analyzed by immunoblotting.
(D) Identification of residues critical for APC binding. C-terminal conserved residues indicated in panel A were mutated by alanine substitution, and
GFP-tagged UL21a mutant proteins were tested for APC binding as described in panel C. (E) The APC binding site of pUL21a was validated during
HCMV infection. MRC-5 cells were infected with recombinant HCMV virus carrying the GFP-tagged UL21aPH-AA or UL21aPR-AA point mutant. Cells were
collected at 48 hpi and lysates were immunoprecipitated with GFP or APC3 antibody. Cell lysates and eluted proteins were analyzed by
immunoblotting. Non-specific cross-reacting bands are indicated by asterisk.
doi:10.1371/journal.ppat.1002789.g002
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to increased proteasome degradation (Figure 4C). These results
were also recapitulated during infection of APC binding mutant
virus ADpmUL21aPR-AA and its control virus ADpmUL21aPH-AA
(Figure 4C).
To confirm that decreased APC substrate accumulation during
mutant virus infection was due to APC activity, we used shRNAs
to knock down APC8 or the coactivator Cdh1 to deplete APC
activity. Both APC8 and Cdh1 shRNAs efficiently reduced
expression of their respective targets (Figures 4D and S5B).
Importantly, APC8 knockdown restored geminin and Cdh1 levels
in cells infected with ADpmUL21aPR-AA or ADsubUL21a virus to
those with ADpmUL21aPH-AA or ADgfp virus. Likewise, Cdh1
Figure 3. pUL21a binding to the APC promotes degradation of APC subunits and APC dissociation. (A) pUL21a is required for HCMV to
reduce APC4 and APC5 accumulation during infection. MRC-5 cells were infected in the presence or absence of PAA with ADgfp or ADsubUL21a. Cell
lysates were analyzed by immunoblotting at 24 hpi. pUL21a, IE1-72, and actin were used as infection and loading controls, respectively. (B) HCMV
infection does not alter APC4 or APC5 transcript levels. MRC-5 cells were infected with ADgfp or ADsubUL21a, total RNA was collected at indicated
times, and APC4 and APC5 transcripts were measured by reverse transcription-coupled quantitative PCR (RT-qPCR) and normalized to that of GAPDH.
(C) APC binding activity of pUL21a is required for proteasome-dependent degradation of APC4 and APC5 in HCMV infection. MRC-5 cells were
infected with ADgfp, ADsubUL21a, ADpmUL21aPH-AA, or ADpmUL21aPR-AA. MG132 was added at 6 hpi, and cell lysates were analyzed at 20 hpi by
immunoblotting. (D) APC binding ability of pUL21a is required for APC dissociation in HCMV infection. MRC-5 cells were infected with ADpmUL21aPH-
AA or ADpmUL21aPR-AA, and treated with MG132 as described in panel C. Cells were collected at 20 hpi, cell lysates were immunoprecipitated with
APC3 antibody, and both lysates and eluted proteins were analyzed by immunoblotting.
doi:10.1371/journal.ppat.1002789.g003
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Figure 4. pUL21a regulates APC activity during HCMV infection. (A) pUL21a is required for elevated accumulation of APC substrate proteins
in HCMV infection. MRC-5 cells were infected with ADgfp or ADsubUL21a, and cell lysates were collected at indicated times and analyzed by
immunoblotting. Protein bands were quantified using Image J software and normalized to the wild-type value at each time point. Results were
reproducible in four independent experiments. (B) pUL21a is not required for geminin transcript accumulation. MRC-5 cells were infected with ADgfp
or ADsubUL21a, and total RNA was collected at indicated times. Geminin transcript was measured by RT-qPCR and normalized to that of GAPDH. (C)
Proteasome-dependent degradation of APC substrates is dependent on the APC binding activity of pUL21a. MRC-5 cells were infected with ADgfp,
ADsubUL21a, ADpmUL21aPH-AA, or ADpmUL21aPR-AA in the presence or absence of MG132. Cell lysates were collected at 20 hpi and analyzed by
immunoblotting. Protein bands were quantified using Image J software and normalized to the wild-type value in each condition. Results were
reproducible in three independent experiments. (D) APC knockdown restores APC substrate accumulation in UL21a mutant virus infection. MRC-5
cells were transduced with lentivirus expressing the indicated shRNA (see Materials and Methods for shRNA sequence). After 48 hours, cells were
infected with ADpmUL21aPH-AA or ADpmUL21aPR-AA, and cell lysates were collected at 72 hpi and analyzed by immunoblotting. Protein bands were
quantified as in panel A with values normalized to that of shLuc-expressing cells infected with ADpmUL21aPH-AA. Results were reproducible in two
independent experiments. (E) Immunoblot analysis of Cdh1 from infected cells. One-fifth or one-tenth equivalent of lysate from ADgfp-infected cells
relative to that from ADsubUL21a-infected cells at 24 or 72 hpi, respectively, was loaded on the SDS-PAGE to differentiate the migration patterns of
Cdh1. For all of the quantitative analyses, the representative results from at least two independent experiments are shown.
doi:10.1371/journal.ppat.1002789.g004
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knockdown restored geminin levels in cells infected with the
pUL21a-deficient viruses. Thus, our results indicate that pUL21a
association with the APC allows it to target APC4 and APC5
subunits for degradation to alter APC activity during infection.
It is noteworthy that not all APC substrates were subjected to
pUL21a-mediated regulation. We did not observe significant
difference in Cdc6 or a drastic reduction in thymidine kinase
protein levels in the UL21a mutant relative to wild-type viral
infection (data not shown). It is possible that these APC substrates
are regulated by multiple mechanisms, including APC-indepen-
dent viral regulation, pUL21a-mediated alteration in APC
substrate specificity, and pUL97-mediated phosphorylation of
the APC coactivator Cdh1. In fact, Cdh1 from both wild type and
UL21a mutant virus infected cells migrated slower in an SDS-
PAGE gel compared to that from mock cells, which was previously
shown to be due to phosphorylation (Figure 4E) [28]. Therefore,
virus-induced, Cdh1 phosphorylation-mediated APC regulation
appears intact even without pUL21a during HCMV infection.
As the APC prevents the premature entry of the cell cycle into S
phase, we predicted that increased APC activity in the absence of
pUL21a would not compromise the ability of HCMV to arrest
infected cells at G1/S phase boundary. Consistent with this
hypothesis, cells infected with wild type, ADpmUL21aPH-AA, or
ADpmUL21aPR-AAvirus showed indistinguishable cell cycle profiles
throughout infection, with the majority of cells phenotypically
arrested in G1 phase (Figure S6).
Figure 5. pUL21a reduces APC4 and APC5 protein levels and inhibits APC activity in an inducible cell line. (A) pUL21a expression is
sufficient to reduce APC4 and 5 protein accumulation. Hela cells constitutively expressing GFP-tagged TetR were transduced with pLKO-derived
lentivirus that expressed pUL21aPH-AA, pUL21astop, or pUL21aPR-AA under a Tet operator (TetO)-regulated CMV promoter. Transduced cells were
enriched by antibiotic selection and pUL21a expression was induced by tetracycline treatment for 72 hours. Cell lysates were collected and analyzed
by immunoblotting. (B) pUL21a expression is sufficient to induce an M-phase cell cycle arrest. Cells carrying pUL21aPH-AA (+/2 tetracycline) were
treated with nocodazole (100 ng/ml) for 16 hours to synchronize cells in G2/M phase. The cells were then released from nocodazole, collected at
indicated time points, and analyzed for DNA content by flow cytometry. (C) pUL21a expression is sufficient to regulate APC activity. Cells from panel B
were also analyzed for APC subunit and substrate levels by immunoblotting.
doi:10.1371/journal.ppat.1002789.g005
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pUL21a Is Sufficient to Reduce APC4 and APC5 Protein
Levels and Alter APC Activity
To test if pUL21a was sufficient to alter APC activity, we first
analyzed 293T cells that over-expressed pUL21a by transient
transfection. Expression of pUL21a alone was sufficient to
markedly reduce the levels of APC4 and APC5 (Figure S7A),
and as expected, geminin and Cdh1 levels were elevated in these
cells. These pUL21a-expressing cells were largely arrested in G2/
M phase (Figure S7B), failed to multiply, and ultimately died
(Figure S7C). The biological characteristics of pUL21a-expressing
cells are therefore consistent with reduced APC activity.
To more precisely test if pUL21a was able to regulate the APC in
the absence of other HCMV proteins, we developed an inducible
pUL21a expression system. We constructed a HeLa cell line stably
expressing a GFP-tagged TetR (tetracycline repressor) gene. We then
transduced this cell line with lentiviruses expressing pUL21astop,
pUL21aPH-AA, or pUL21aPR-AA under a CMV-TetO (tetracycline
operator) promoter. pUL21a protein accumulation was only detected
in the presence of tetracycline, suggesting tight regulation of pUL21a
expression (Figure 5A), although its levels were significantly lower
than those expressed in transiently transfected cells (Figure S7A).
Importantly, the addition of tetracycline significantly reduced APC4
and APC5 protein levels in cells expressing pUL21aPH-AA, but not
pUL21astop or pUL21aPR-AA. To assess the consequence of pUL21a
on APC activity, we synchronized cells expressing pUL21aPH-AA (i.e.
wild-type pUL21a) in mitosis with nocodazole and then assayed their
ability to progress out of mitosis after release from nocodazole
treatment. In the absence of tetracycline and pUL21a, cells readily
progressed through the mitotic phase following release. In the
experiment shown in Figure 5B, 26% and 48% of cells entered the
next G1 phase by 2 and 4 hours, respectively. In the presence of
tetracycline where pUL21a was expressed, progression through the
mitotic phase was clearly delayed. As the result, only 5% and 24% of
cells reached G1 by 2 and 4 hours, even though by 8 hours most of
pUL21a-expressing cells were able to enter G1, likely due to low
expression of pUL21a in these cells as compared to those in
transiently transfected cells. Additionally, following nocodazole
withdrawal, APC substrates geminin and cyclin B1 remained elevated
in the presence of tetracycline while their levels were reduced in its
absence (Figure 5C). Our results provide strong evidence that
pUL21a expression alone is sufficient to regulate APC activity.
Abrogation of Both pUL21a APC Regulatory Activity and
pUL97 Results in a More Severe Attenuation in HCMV
Growth than pUL97 Deletion Alone
In the final experiments, we tested the consequence of pUL21a-
mediated APC regulation on HCMV replication in fibroblasts. We
first tested if the ability of pUL21a to regulate the APC would be
responsible for its previously reported role in promoting viral DNA
replication [30]. We compared the growth of ADpmUL21aPR-AA
mutant virus (i.e. pUL21a APC-binding deficient) to that of wild-
type, ADpmUL21aPH-AA (i.e. pUL21a APC-binding competent),
or UL21a deletion viruses in multi-step growth curve analysis. We
found that ADpmUL21aPR-AA grew indistinguishably from wild-
type and ADpmUL21aPH-AA viruses in both cycling and G0-
synchronized fibroblasts, whereas the UL21a deletion virus had a
100-fold defect (Figure 6A) [29]. Furthermore, knockdown of
Cdh1 and APC8 was unable to enhance UL21a-deletion virus
replication (data not shown). This suggests that pUL21a has at
least two independent activities. One is to facilitate viral DNA
replication via an unknown mechanism and is responsible for the
growth defect of UL21a deletion virus. The second activity is to
regulate the APC, whose impact on virus replication is not
apparent under the aforementioned experimental conditions.
As two HCMV proteins, pUL97 and pUL21a, are capable of
regulating the APC, we hypothesized that one of these two
proteins acted to compensate for the loss of the other during
infection. Consistent with this hypothesis, HCMV appeared to
retain the ability, at least to some extent, to regulate the APC even
when pUL21a or pUL97 is absent (Figure 4E, and data not shown)
[24]. To test this hypothesis more directly, we created recombi-
nant HCMV viruses ADpmUL21aPH-AA/subUL97 and ADpmU-
L21aPR-AA/subUL97. The two viruses were derived from AD-
pmUL21aPH-AA and ADpmUL21aPR-AA, respectively, and both
contained an additional deletion in UL97. Both recombinant
viruses grew slower than wild-type virus due to lack of the
multifunctional pUL97 protein (Figure 6C). However, reconstitu-
tion of ADpmUL21aPR-AA/subUL97 that lacked pUL21a APC-
binding activity following BAC transfection was markedly slower
than that of ADpmUL21aPH-AA/subUL97 (Figure 6B). At day 25
post transfection, while cells transfected with the BAC clone of
ADpmUL21aPH-AA/subUL97 showed nearly 100% of CPE indi-
cated by virus-driven GFP expression, GFP-positive foci in cells
transfected with the BAC clone of ADpmUL21aPR-AA/subUL97
were distinctly smaller. Furthermore, multi-step growth curve
analysis showed that titers of ADpmUL21aPR-AA/subUL97 were
13- and 14- fold lower than that of ADpmUL21aPH-AA/subUL97 at
14 and 21 days post infection (dpi), respectively (Figure 6C). As a
control to show that this phenotype was not due to general viral
attenuation resulting from the UL97 deletion, we also constructed
double mutant viruses ADpmUL21aPH-AA/subUL117 and AD-
pmUL21aPR-AA/subUL117. These two viruses were derived
similarly from ADpmUL21aPH-AA and ADpmUL21aPR-AA, but
also contained a deletion in viral gene UL117. We chose UL117 as
the control because its mutation attenuated virus growth but not
viral early or early-late gene expression so UL97 expression was
unlikely affected [34]. BAC transfection reconstituted both mutant
viruses at similar efficiency and produced viruses with similar titers
(data not shown). Multi-step growth analysis demonstrated that
ADpmUL21aPH-AA/subUL117 and ADpmUL21aPR-AA/subUL117
Figure 6. Abrogation of both pUL21a APC regulatory activity and pUL97 results in a more severe attenuation in HCMV growth than
pUL97 deletion alone. (A) Abrogation of pUL21a-APC binding alone is not sufficient to alter HCMV replication. MRC-5 cells in serum-containing
(cycling condition) or serum-free (G0 condition) media were infected with ADgfp, ADsubUL21a, ADpmUL21aPH-AA, or ADpmUL21aPR-AA at an MOI of
0.01. Production of cell-free virus at indicated times was determined by plaque assay. (B) Abrogation of both UL97 and the pUL21a-APC binding site
markedly reduced the efficiency of HCMV reconstitution as compared to abrogation of UL97 alone. To reconstitute ADpmUL21aPR-AA/subUL97 and
pADpmUL21aPH-AA/subUL97 viruses, MRC-5 fibroblasts were transfected with their corresponding BAC clones. For each recombinant virus, three
independent clones were tested. Shown are representative images of virus spread indicated by virus-driven GFP expression at indicated days post
transfection of two of the three clones. Images were taken under a Leica fluorescent microscope. (C) Abrogation of both UL97 and the pUL21a-APC
binding site markedly reduced HCMV replication as compared to abrogation of UL97 alone. MRC-5 cells were infected with indicated recombinant
viruses at an input genome number equivalent to that of 0.03 infectious units of wild type virus/cell. Production of cell-free virion DNA at indicated
times was determined by qPCR analysis and normalized to input levels of ADpmUL21aPH-AA, which was set to 1. (D) Multi-step growth analysis of
double mutant viruses that carried the UL117 deletion and point mutation in the UL21a-APC binding site. Cells were infected with indicated
recombinant viruses and analyzed as described in panel C. The input value of ADgfp was set to 1.
doi:10.1371/journal.ppat.1002789.g006
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replicated at similar kinetics (Figure 6D). At 14 dpi, the titer of
ADpmUL21aPR-AA/subUL117 was slightly lower (e.g. 1.5-fold)
than that of ADpmUL21aPH-AA/subUL117. However, growth of
mutant virus carrying only the UL117 deletion tracked with
ADpmUL21aPR-AA/subUL117, suggesting that the difference
between the PH and PR mutants at 14 dpi, if any, is minimal.
Together, our data provide evidence that disruptions of both
pUL97 and the APC regulatory activity of pUL21a are
synthetically lethal to HCMV replication. This is consistent with
a working model that these two functions enable HCMV to cope
with APC activity to promote virus replication (Figure 7).
In sum, we have shown that the HCMV protein pUL21a
antagonizes the APC by promoting proteasome-mediated disrup-
tion of this prominent cellular E3 ubiquitin ligase.
Discussion
HCMV has been shown to have two different means to regulate
the anaphase-promoting complex (APC) during infection
[24,27,28]. It can induce phosphorylation of APC co-activator
Cdh1, and it induces dissociation of the complex by promoting
proteasomal degradation of two components of the bridge
subcomplex, APC4 and APC5. The viral protein pUL97 appears
to be responsible for Cdh1 phosphorylation [24]. However,
pUL97 is an HCMV-encoded kinase that has many reported roles
[26,35]. How this particular pUL97 activity impacts HCMV
infection remains elusive. Importantly, the viral factor or precise
molecular mechanism mediating APC4 and APC5 degradation
has not been identified, and how APC disruption contributes to
HCMV replication is not known. Here, we have identified the
HCMV protein pUL21a as the viral factor that mediates APC
disruption. It does so by interacting with the APC and inducing
proteasome-dependent degradation of APC4 and APC5, which
results in complex dissociation. This is the first identified viral
protein that modulates the APC in this manner. We also show, for
the first time, the impact of viral modulation of the APC,
particularly by pUL21a, on HCMV replication. Loss of pUL21a-
mediated APC regulation has minimal impact on virus replication
Figure 7. Working model of virus-mediated APC regulation during HCMV infection. HCMV uses two mechanisms to regulate the APC
during infection. The pUL97 viral kinase inhibits the APC co-activator Cdh1 by phosphorylation while pUL21a targets APC4 and APC5 for proteasome-
dependent degradation to dissociate the complex.
doi:10.1371/journal.ppat.1002789.g007
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but the combined loss of both pUL97- and pUL21a-mediated
regulation markedly attenuates growth of the virus relative to
single loss of pUL21a- or pUL97- mediated regulation. Our
studies support a working model in which HCMV uses pUL97-
mediated Cdh1 phosphorylation and pUL21a-mediated complex
disruption to control APC activity for efficient virus infection
(Figure 7). Why has HCMV developed these two distinct
mechanisms that seemingly lead to a similar biological conse-
quence? It is possible that these two mechanisms have differential
roles in HCMV infection under different conditions or in
particular cell types, even though either one seems sufficient and
can compensate for loss of the other in fibroblasts. Alternatively, it
is possible that these two mechanisms serve as the fallback for one
another or act synergistically to maximize the ability of the virus to
acquire a complete control of the APC during infection. In any
event, the fact that HCMV uses multiple means to subvert the
APC underlines its critical role in HCMV infection. This is
particularly true for large DNA viruses such as HCMV, which
often encode multiple viral factors to regulate the same or related
cellular targets central to their infection [36]. However, it is often
challenging to dissect these intertwined viral mechanisms during
infection because of the presence of other factors targeting the
same process. The regulation of the APC represents one such
critical but complex viral regulatory strategy, and our studies shed
light into its role and mechanism during HCMV infection.
Several viral factors from different viral families have been
reported to use diverse mechanisms to regulate the APC. For
instance, the human papillomavirus E2 protein binds to and
inhibits the Cdh1 activator protein [20], while the parapoxvirus
virus protein PACR (poxviral APC regulator) functions as an
enzymatically inactive APC11 mimic [23,37]. The chicken anemia
virus (CAV) protein apoptin can bind to the APC at the bridge
and cause its dissociation using an unknown mechanism [19]. The
fact that proteins from both HCMV and CAV target the APC
bridge subcomplex suggests that viruses have evolved regulatory
strategies converging on this sub-complex as an efficient means to
disable APC activity. It is intriguing to speculate that modulating
the APC complex by dissolving the bridge may allow viruses to
alter substrate specificity of the APC instead of completely
abolishing its activity, as the enzymatic portion of APC is known
to have activity in vitro [23,38]. HCMV does not appear to directly
destroy the enzymatic subcomplex of APC, so it is of interest to
determine if the APC retains some activity or is directed to target
different substrates during virus infection.
Several viral proteins have now been reported to regulate the APC
in overexpression, and evidence correlating the role of these factors
and viral replication is emerging. Deletion of the parapoxvirus PACR
or CAV protein apoptin markedly attenuated virus growth in tissue
culture even though their ability and role in inhibiting the APC
during infection has not been clarified [23,39]. Recently, the UL97
kinase of HCMV has been shown to phosphorylate Cdh1 and
partially inhibit the APC during infection but with unknown
consequences for viral replication [24]. Our study elucidates the
mechanism by which pUL21a regulates APC in the context of virus
infection and indicates a role of this pUL21a activity in viral
replication. Mutation abolishing the APC binding activity of pUL21a
had no impact on viral growth in tissue culture, but the loss of both
pUL21a-APC binding and pUL97 markedly attenuated viral
replication relative to the loss of pUL97 alone. Our data suggest
that HCMV has evolved a sophisticated strategy by encoding both
pUL97 and pUL21a to overcome APC activity. However, further
experiments are needed to unequivocally demonstrate the vital role of
APC regulation in HCMV replication and provide mechanistic
insight into how this regulation impacts its biology.
How does pUL21a target APC4 and APC5 for proteasome
degradation? pUL21a does not contain a sequence domain that
would suggest it as an E3 ligase, thus likely ruling out this
possibility. Currently, we also do not know which subunit of the
APC complex that pUL21a directly binds to so the precise
mechanism that it uses to degrade APC4 and APC5 remains
elusive. It is certainly possible that pUL21a may bind to a subunit
neighboring to APC4 and APC5 so it can disrupt the APC
structure leading to APC4 and APC5 degradation, or recruit a
protein degradation enzyme (e.g. E3 ubiquitin ligase) to destabilize
the subunits. However, knockdown of APC8 does not abrogate the
ability of pUL21a to degrade APC4 and APC5, suggesting that
APC8 is not involved and the presence of the entire complex is not
required. Intriguingly, pUL21a itself is a highly unstable protein
and likely degraded in a ubiquitin-independent manner [29,40]. It
is tempting to speculate that pUL21a may directly bind APC4 and
APC5 and target them for degradation in a ubiquitin-independent
manner. One focus of future work is to identify the APC
component that pUL21a directly binds to and elucidate the
mechanism of how pUL21a targets APC4 and APC5 to the
proteasome.
What would be the benefit for the virus to alter APC activity?
The APC may restrict HCMV replication via several mechanisms.
The APC not only promotes cell cycle progression through M
phase, it also prevents cells from prematurely entering S phase.
Thus virus-mediated APC regulation may help HCMV maintain
an S phase-like cellular environment for viral replication. The
APC targets more than 40 proteins for degradation, so it may
deplete host factors critical to viral replication. Consequently,
viruses may need to alter the substrate specificity of the APC or
allow accumulation of APC substrates critical for viral replication.
Interestingly, the only viruses within the poxvirus and herpesvirus
families that are known to modulate the APC (e.g. parapoxviruses
and HCMV) are those that do not encode viral thymidine kinase
(TK) and ribonucleotide reductase subunit M2 (RRM2). Both
enzymes are APC substrates and critical for the production of
deoxyribonucleotides. It is tempting to speculate that this viral
regulation of the APC may provide viruses a means to produce
sufficient nucleotides to replicate their genome [23,27]. Nonethe-
less, the APC also targets proteins involved in cellular DNA
synthesis, glycolysis and glutaminolysis, and cell cycle progression,
all of which could impact viral replication [41]. Moreover, the
APC may also promote ubiquitination and degradation of viral
proteins to restrict infection [42]. Several HCMV proteins contain
a putative destruction Box (D-box) motif, an APC recognition
signal commonly found in its substrates [24]. Future work is
needed to differentiate these possibilities and unravel the APC
substrates that may be critical for viral replication.
Insight into the mechanism of pUL21a-mediated APC regula-
tion may also have broad impact on cancer and neuronal disease.
Due to its essential role in cell cycle progression, the APC is a
promising target for novel anti-cancer therapeutics [16,43]. In
fact, we found in this study that overexpression of pUL21a
essentially prevented the proliferation of a transformed cell line
(Figure S7), suggesting that pUL21a regulation of the APC could
inhibit cancer cell growth. Furthermore, several recent studies
have also highlighted a vital role of the APC in neuronal
development (for a review, see [44]). HCMV infects neuronal cells
and congenital HCMV infection leads to neuronal disease and
severe complications such as blindness, hearing loss, and mental
retardation. It is reasonable to speculate that inhibition of the APC
by pUL21a may play a role in promoting neuronal disease in
congenitally infected infants. Therefore, an understanding of
pUL21a-APC interaction may reveal novel mechanisms of APC
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assembly and regulation, give further impetus to target the APC
for anti-cancer therapies, and uncover new insights into the
molecular basis of HCMV pathogenesis.
Materials and Methods
Plasmids and Reagents
Primary embryonic lung fibroblasts (MRC-5), human newborn
foreskin fibroblasts (HFFs), 293T, and Hela cells were propagated
in Dulbecco’s modified Eagle medium (DMEM) supplemented
with 10% fetal bovine serum, non-essential amino acids, and
penicillin-streptomycin. Transient transfection of expression con-
structs were carried out using lipofectamine according to the
manufacturers’ instructions.
pYD-C235 is a pLPCX-derived retroviral vector (Clontech) that
expresses a DsRed gene driven by an internal ribosome entry site 2
(IRES2) [45]. pYD-C474 was created by PCR amplifying the
coding sequence of the pGFP-UL21a fusion protein from
pADgfpUL21a (see below) and ligating it into the multiple cloning
site of pYD-C235. pYD-C580 was created by replacing the coding
sequence of wild-type UL21a in pYD-C474 with that of mutant
UL21a carrying two stop-codon mutations at the N-terminus (i.e.
UL21astop) [30]. Vectors expressing pGFP-UL21a truncation
mutants were derived from pYD-C235 while vectors expressing
point mutants were derived from pYD-C474. Truncation mutants
were made by PCR amplifying the targeted UL21a coding
sequences and point mutants were created using a QuickChange
XL kit (Stratagene). Primers used to create these mutants are listed
in Table S2. pYD-C160, pYD-C175, and pYD-C682 are pRetro-
EBNA derived retroviral expression vectors that expressed GFP,
UL21a, and UL21astop, respectively. pYD-C648 and pYD-C649
are pLKO-based lentiviral vectors expressing GFP-TetR and
carrying the CMV-TetO2 promoter, respectively (generous gifts
from Roger Everett, University of Glasgow Centre for Viral
Research) [46]. YD-C665, YD-C667, and YD-C669 are lentiviral
expression vectors created by cloning the UL21astop, UL21aPH-AA,
and UL21aPR-AA sequences into the multiple cloning site of YD-
C649. To produce pLKO-based lentiviruses, 293T cells were
transfected with corresponding pLKO vectors along with packag-
ing plasmids. Lentivirus was collected at 48 and 72 hours and used
to transduce MRC-5 cells. To create GFP-TetR expressing stable
cells, Hela cells were transduced with pYD-C648 derived lentivirus
and sorted for GFP expression 48 hours later. GFP-positive cells
were collected, grown in the presence of G418 (500 mg/ml), and
frozen as cells stably expressing GFP-TetR. These stable cells were
then transduced with lentivirus derived from YD-C665, YD-C667,
and YD-C669, selected with puromycin (2 mg/ml), and tested for
tetracycline (1 mg/ml)-regulated expression of targeted genes.
For shRNA knockdown, MRC-5 cells were transduced with
pLKO-based lentivirus expressing shRNA against the targeted
gene for 48 hours. The shRNA sequence for Cdh1 knockdown
was 59CCAGTCAGAACCGGAAAGCCA39 and the shRNA
sequence for APC8 knockdown was 59GCAGGAGGTAA-
TATGCTATAA39. All pLKO-based shRNA lentiviral vectors
were purchased from the Washington University Children’s
Discovery Institute/Genome Center.
The primary antibodies used in this study included anti-b actin
(AC-15, Abcam); anti-HA (HA.11, Covance); anti-GFP (3E6 and
A6455, Invitrogen); anti-APC3 (AF3.1, Santa Cruz and 610454,
BD); anti-APC8 (6114, Biolegend); anti-APC4 (A301-176A, Bethyl
laboratories); anti-APC5 (A301-026A, Bethyl laboratories); anti-
geminin (sc-13015, Santa Cruz); anti-Cdh1 (DH01, Calbiochem);
anti-cyclin B1 (ms868 P1, Thermo-Scientific); anti-UL21a [29];
anti-IE2 (mAB8140, Chemicon); and anti-IE1 and anti-pp28
(generous gifts from Thomas Shenk, Princeton University) [45].
Phosphonoacetic acid (PAA), MG132, tetracycline, gancyclovir
(GCV), and propidium iodide (PI) were purchased from Sigma-
Aldrich. Lipofectamine 2000 and Protein A-conjugated Dyna-
beads were purchased from Invitrogen.
Recombinant HCMV Viruses
Recombinant HCMV AD169 viruses were reconstituted from
transfection of corresponding BAC-HCMV clones as previously
described [34]. Viral stocks were prepared by ultra-centrifugation
of infected culture supernatant through 20% D-sorbitol cushion
and re-suspending pelleted virus in serum-free medium. The
following BAC-HCMV clones were used in the present study, and
were constructed using PCR-based linear recombination as
previously reported [29], unless indicated otherwise. pAD-GFP,
which carried the GFP-tagged genome of the HCMV AD169
strain, was used to produce wild-type virus ADgfp [45].
pADgfpUL21a, which carried an N-terminally GFP-tagged version
of pUL21a, was used to produce ADgfpUL21a virus [29].
pADsubUL21a, which carried a GalK/kanamycin dual mutagenic
cassette in place of the UL21a coding sequence, was used to
produce UL21a-deletion virus ADsubUL21a [29]. pADgfpU-
L21aPR-AA, pADgfpUL21aPH-AA, pADpmUL21aPR-AA, or pADp-
mUL21aPH-AA carried point mutation PR109-110AA or PH111-
112AA in the GFP tagged or native UL21a gene, respectively.
These recombinant BAC clones were used to produce corre-
sponding point mutant viruses. pADpmUL21aPH-AA/subUL97 and
pADpmUL21aPR-AA/subUL97 carried the GalK/kanamycin mu-
tagenic cassette in place of UL97 on the background of
pADpmUL21aPR-AA and pADpmUL21aPH-AA BAC clones. Simi-
larly, pADpmUL21aPH-AA/subUL117, pADpmUL21aPR-AA/
subUL117, and pADsubUL117 carried the GalK/kanamycin
mutagenic cassette in place of UL117 on the background of
pADpmUL21aPR-AA, pADpmUL21aPH-AA, and pAD-GFP BAC
clones, respectively. All BACs were confirmed by restriction
digestion, PCR, and sequencing. HCMV virus titers were
determined in duplicate in HFFs by tissue culture infectious dose
50 (TCID50) assay or plaque assay. Relative viral genome numbers
were determined by real-time quantitative PCR (qPCR) as
described previously [29].
HCMV Infection
For most infections, subconfluent MRC-5 cells in serum-
containing medium were inoculated with recombinant HCMV
virus at an input genome number equivalent to that of 3–5
infectious units of wild type virus/cell for 1 hour, unless otherwise
indicated. Inoculum was removed and fresh medium was
replenished. For infection of G0-synchronized cells, MRC-5 cells
were incubated in serum-free medium for 72 hours, infected as
described above, and maintained in serum-free media throughout
the infection. For shRNA knockdown experiments, subconfluent
MRC-5 cells were transduced with lentivirus for 24 hours,
incubated in fresh medium for additional 48 hours, and infected
as described above. When necessary, PAA (100 mg/ml) was added
immediately following infection, and MG132 (10 mM) was added
12–14 hours prior to harvest. For viral growth analysis, virus
production in the media of infected cultures was determined by
TCID50, plaque assay, or qPCR. For qPCR analysis, virion DNA
was prepared as previously described [29]. Briefly, cell-free
supernatants were treated with DNase I to remove contaminating
DNA, and virions were lysed with proteinase K and SDS. DNA
was extracted with phenol/chloroform/isoamyl alcohol and
precipitated with ethanol. The DNA was subjected to qPCR
using primers and a taqman probe specific for UL54.
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Protein Analysis
For immunoprecipitation, frozen cell pellets were lysed in lysis
buffer (0.5% NP-40, 50 mM Tris-Cl pH 8.0, 125 mM NaCl,
supplemented with protease and phosphatase inhibitors) using an
end-over-end rotator at 4uC for 30 minutes. Cell extracts were
cleared by centrifugation at 16,0006 g for 15 minutes. Superna-
tants were incubated with protein A-coated Dynabeads that were
coupled to 1 mg anti-HA (HA.11, Covance), 1 mg anti-GFP (3E6,
Invitrogen) or 2 mg anti-APC3 (AF3.1, Santa Cruz) mouse
monoclonal antibodies at 4uC for 1–2 hours. Beads were washed
with PBS and immunoprecipitated protein complexes were eluted
by boiling beads in reducing sample buffer for 5 minutes. Cell
extracts (pre-IP) were also collected and boiled in reducing sample
buffer. For mass spectrometry analysis, protein complexes were
resolved by SDS-polyacrylamide gel electrophoresis (Invitrogen)
followed by staining with a silver stain kit (Sigma-Aldrich). Protein
bands specific to immunoprecipitated pUL21a complex were
excised for identification by MS/MS mass spectrometry [47].
For immunoblotting, total cell or pre-IP extracts were lysed in
sample buffer containing SDS and protease and phosphatase
inhibitors. Proteins were resolved on a SDS polyacrylamide gel,
transferred to a polyvinylidene difluoride (PVDF) membrane,
hybridized with a primary antibody, reacted with the horseradish
peroxidase-conjugated secondary antibody, and visualized using
chemiluminescent substrate (Thermo Scientific).
Reverse Transcription Coupled-Quantitative PCR Analysis
(RT-qPCR)
Total RNA was extracted with TRIzol (Invitrogen) and treated
with Turbo DNA-free reagent (Ambion) to remove genomic DNA
contaminants. cDNA was reverse transcribed from total RNA with
random hexamer primers using the High Capacity cDNA reverse
transcription kit (Applied Biosystems). cDNA was quantified using
SYBR Advantage qPCR Premix (Clontech) and primers for the
cellular genes geminin, APC4, APC5, and GAPDH (glyceralde-
hyde-3-phosphate dehydrogenase) as an internal control (see
below). cDNA from infected cells was used to generate a standard
curve for each gene examined. The standard curve was then used
to calculate the relative amount of specific RNA present in a
sample.
Primers used for RT-qPCR are as follows: geminin, forward
59GCCTTCTGCATCTGGATCTCTT39 and reverse 59CGAT
GTTTCCTTTTGGACAAGC39 [24]; APC4, forward 59ATT
CTCGTCCTTGGAGGAAGCTCT39 and reverse 59TTCTG
GCCATCCGAGTTACTTCAG39 [24]; APC5, forward 59GTG
CCATGTTCTTAGTGGCCAAGT39 and reverse 59GATGCG
CTCTTTGCAGTCAACCTT-39 [24]; GAPDH, forward 59CT
GTTGCTGTAGCCAAATTCGT39 and reverse 59ACCCACT
CCTCCACCTTTGAC39 [30].
Analysis of Cellular DNA Content
To determine cellular DNA content, cells were trypsinized,
collected by low-speed centrifugation, fixed, and permeabilized in
ice-cold 70% ethanol overnight. Cells were stained with propidium
iodide only, or double-stained with propidium iodide and anti-
pUL44 antibody to identify HCMV-infected cells. Total or pUL44-
positive cells were determined for their DNA content by cell-cycle
analysis with flow-cytometry. Percentages of cells in each cell cycle
compartment were calculated using CellQuest or FlowJo software.
Supporting Information
Figure S1 APC8 knockdown by shRNA. MRC-5 cells were
transduced with lentivirus expressing shRNA targeting either Luc
(negative control) or APC8. Forty-eight hours post transduction,
cells were infected with mock, wild-type (ADgfp), or UL21a-
deletion virus (ADsubUL21a). Cell lysates were collected at 72 hpi
and analyzed by immunoblotting. Note that the asterisk-marked
bottom band that reacted with the APC8 antibody was nonspecific
as it was not affected by the APC8-targting shRNA.
(TIF)
Figure S2 Amino acid residues PR109–110 of pUL21a are
required for its APC binding during HCMV infection. Cells were
infected with indicated virus and MG132 was added to the final
concentration of 10 mM at 6 hpi. Cells were collected at 20 hpi
and lysates were immunoprecipitated with APC3 antibody. Cell
lysates and eluted proteins were analyzed by immunoblotting.
(TIF)
Figure S3 pUL21a dissociates the APC by promoting degrada-
tion of the bridge subcomplex. MRC-5 cells were infected with
ADgfp or ADsubUL21a, and MG132 was added to the final
concentration of 10 mM at 6 hpi. Cells were collected at 20 hpi
and lysates were immunoprecipitated with APC3 antibody. Both
cell lysates and eluted proteins were analyzed by immunoblotting.
(TIF)
Figure S4 APC8 is not required for pUL21a-mediated degra-
dation of APC4 and APC5. Knockdown and subsequent
immunoblot were performed as described in the legend to Figure
S1.
(TIF)
Figure S5 pUL21a regulates APC activity during HCMV
infection. (A) Reduced accumulation of APC substrates during
UL21a mutant virus infection is not due to a defect in viral late
gene expression. MRC-5 cells were infected with ADgfp or
ADsubUL21a in the presence or absence of PAA. Cells were
collected at 72 hpi, and lysates were analyzed by immunoblotting.
(B) APC knockdown restores APC substrate accumulation during
UL21a mutant virus infection. MRC-5 cells were transduced with
lentivirus expressing indicated shRNA. 48 hours post transduc-
tion, cells were infected with ADgfp or ADsubUL21a. Cells were
collected at 72 hpi, and lysates were analyzed by immunoblotting.
Protein bands were quantified using Image J software and
normalized to the value of shLuc-expressing cells infected with
ADgfp virus. Results were reproducible in three independent
experiments.
(TIF)
Figure S6 Loss of pUL21a-mediated APC regulation does not
compromise HCMV’s ability to block cellular DNA synthesis. (A)
Cell cycle profiles at 48 hpi of MRC-5 cells that were mock
infected or infected with ADgfp, ADpmUL21aPH-AA, or ADpmU-
L21aPR-AA. (B) Percentage of cells in each compartment of the cell
cycle at 24 and 48 hpi.
(TIF)
Figure S7 Transient expression of pUL21a reduces APC4 and
APC5 protein levels and inhibits cell proliferation. 293T cells were
transfected with plasmid expressing GFP, UL21a, or UL21astop,
and selected with puromycin treatment for 72 hours. (A) Analysis
of indicated protein accumulation by immunoblotting. (B) Analysis
of cellular DNA content by flow cytometry. (C) Analysis of cell
proliferation by plating 16105 cells and counting cells at indicated
days.
(TIF)
Table S1 pUL21a interacting proteins identified by mass
spectrometry.
(DOC)
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Table S2 Primers used to create mutations in UL21a.
(DOC)
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